2021-07-27

Clinical evidence that a dysregulated master neural network modulator mayaid in diagnosing schizophrenia

Patients with type 2 diabetes mellitus (T2DM) and obesity are at high risk of developing cardiovascular disease (CVD). Both glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter (SGLT-2) inhibitors have been shown to prevent CVD in T2DM patients.
2021-07-01

Online PBL Session with the University of Hawaii John A. Burns School of Medicine

The YCU School of Medicine always sees the importance of offering our students world-standard medical education. As a part of our efforts, we have sent more than 10 faculty members in past years to the “PBL* Hawaii Style Workshop” organized by the University of Hawaii John A. Burns School of Medicine (JABSOM),
2021-04-16

Medical Education Amidst the COVID-19 Pandemic (International Online Exchange with NUS)

On January 29th 2021, the School of Medicine successfully conducted the International Online Exchange event “Medical Education Amidst the COVID-19 Pandemic” with the National University of Singapore (NUS). This is the second trial of this activity at the School of Medicine being solely online since the onset of the COVID-19 Pandemic.
2021-01-01

New Year Message from the President